Oppenheimer & Co. Inc. Reduces Position in ADMA Biologics, Inc. (NASDAQ:ADMA)
Oppenheimer & Co. Inc. cut its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 59.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,416 shares of the biotechnology company’s stock after selling 56,522 shares during the period. […]
Oppenheimer & Co. Inc. cut its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 59.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,416 shares of the biotechnology company’s stock after selling 56,522 shares during the period. […]
